Site notifications

Sub menu

 

 

​Galantamine Extended-Release Capsules, USP 24mg (Aurobindo, USA)

Section 19A approved medicine
​Galantamine Extended-Release Capsules, USP 24mg (Aurobindo, USA)
Section 19A approval holder
​Link Medical Products Pty Ltd​ ABN ​73 010 971 516
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack - ARTG 182034
GAMINE XR galantamine (as hydrobromide) 24mg modified release capsules blister pack - ARTG 182040
REMINYL galantamine 24mg (as hydrobromide) modified release capsule blister pack - ARTG 97887
Indication(s)
​​

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type.​

Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Details/galantamine-hydrobromide
Images
Picture of Galantamine extended release capsules USP 24mg - bottle label